Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Robert A. Higham"'
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
Background Topical treatments are the foundation for patients with psoriasis; however, adherence can be limited by patient preferences and treatment burden.Methods The Harris Poll conducted an online survey of US patients with psoriasis who use presc
Externí odkaz:
https://doaj.org/article/f38b267d0da34c21b35f0d4af7451f1d
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 7, Pp 1839-1847 (2024)
Abstract Introduction A survey was conducted by The Harris Poll on behalf of Arcutis Biotherapeutics in the USA to understand perspectives and burden of patients with psoriasis using prescription topical treatments for their disease. This manuscript
Externí odkaz:
https://doaj.org/article/1d3338f3c7f042d28bd142feafd938cd
Autor:
Linda Stein Gold, Javier Alonso-Llamazares, Zoe D. Draelos, Melinda J. Gooderham, Steven E. Kempers, Leon H. Kircik, Mark G. Lebwohl, Kim A. Papp, David M. Pariser, Darryl P. Toth, Gil Yosipovitch, Robert C. Higham, Amy Feng, David R. Berk
Publikováno v:
American Journal of Clinical Dermatology. 24:305-313
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b65648ce45871b894bc0e0c6516e906c
https://doi.org/10.1007/s40257-022-00739-3
https://doi.org/10.1007/s40257-022-00739-3
Autor:
Zoe D Draelos, David N Adam, H Chih-ho Hong, Mark G Lebwohl, Charles W Lynde, Walter K Nahm, Kim A Papp, David M Pariser, Linda Stein Gold, Daniel Stewart, Robert C Higham, David R Berk, David Krupa, Patrick Burnett
Publikováno v:
British Journal of Dermatology. 188:810-812
This post hoc analysis evaluated efficacy and safety of roflumilast cream in patients with psoriasis involving the face/neck or intertriginous areas from a phase IIb trial. Of 331 patients enrolled in the phase IIb trial, 160 had psoriasis involving
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31b6566569b004a78c9b5ea14a9890b8
https://doi.org/10.1093/bjd/ljad060
https://doi.org/10.1093/bjd/ljad060
Autor:
Matthew J. Zirwas, Zoe D. Draelos, Janet DuBois, Leon H. Kircik, Angela Y. Moore, Linda Stein Gold, Javier Alonso-Llamazares, Michael Bukhalo, Suzanne Bruce, Kimmie Eads, Lawrence J. Green, Scott T. Guenthner, Laura K. Ferris, Seth B. Forman, Steven E. Kempers, Edward Lain, Charles W. Lynde, David M. Pariser, Darryl P. Toth, Paul S. Yamauchi, Robert C. Higham, David Krupa, Patrick Burnett, David R. Berk
Publikováno v:
JAMA Dermatology.
ImportanceCurrent topical treatment options for seborrheic dermatitis are limited by efficacy and/or safety.ObjectiveTo assess safety and efficacy of roflumilast foam, 0.3%, in adult patients with seborrheic dermatitis affecting the scalp, face, and/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca1dec1f89c02bd2aeda1f7193cbee56
https://doi.org/10.1001/jamadermatol.2023.0846
https://doi.org/10.1001/jamadermatol.2023.0846
Autor:
David R. Berk, Gerald G. Krueger, Kim A. Papp, David M. Pariser, Robert C. Higham, Lynn Navale, Leon H Kircik, Mark Lebwohl, Bruce Strober
Publikováno v:
Dermatology and Therapy
The Psoriasis Area and Severity Index (PASI) is the most widely used clinical measure in clinical trials to assess disease severity of plaque psoriasis. However, the PASI is not a precise measure of severity with less precision when the regional area
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6efce8526efa5ffad4d2a2794443fb0a
https://doi.org/10.1007/s13555-021-00572-2
https://doi.org/10.1007/s13555-021-00572-2
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 6:s56
N/A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e9b3eba3e7e84f64447425a5f80e7d7
https://doi.org/10.25251/skin.6.supp.56
https://doi.org/10.25251/skin.6.supp.56
Autor:
Laura K Ferris, April W Armstrong, James Del Rosso, Zoe D Draelos, Melinda Gooderham, Mark Lebwohl, Kim A Papp, Jennifer Soung, Linda Stein Gold, David Krupa, Robert C Higham, Patrick Burnett, David R Berk
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 6:s57
N/A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ad773711b7679cb7e5e931d853c9b1d
https://doi.org/10.25251/skin.6.supp.57
https://doi.org/10.25251/skin.6.supp.57
Autor:
Mark G, Lebwohl, Leon H, Kircik, Angela Y, Moore, Linda, Stein Gold, Zoe D, Draelos, Melinda J, Gooderham, Kim A, Papp, Jerry, Bagel, Neal, Bhatia, James Q, Del Rosso, Laura K, Ferris, Lawrence J, Green, Adelaide A, Hebert, Terry, Jones, Steven E, Kempers, David M, Pariser, Paul S, Yamauchi, Matthew, Zirwas, Lorne, Albrecht, Alim R, Devani, Mark, Lomaga, Amy, Feng, Scott, Snyder, Patrick, Burnett, Robert C, Higham, David R, Berk
Publikováno v:
JAMA. 328:1073
ImportanceOnce-daily roflumilast cream, 0.3%, a potent phosphodiesterase 4 inhibitor, demonstrated efficacy and was well tolerated in a phase 2b trial of patients with psoriasis.ObjectiveTo evaluate the efficacy of roflumilast cream, 0.3%, applied on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::565d537d0b59fe6b651c8d0f333ec1af
https://doi.org/10.1001/jama.2022.15632
https://doi.org/10.1001/jama.2022.15632
Autor:
Linda Stein Gold, Jerry Bagel, James Del Rosso, Lawrence J. Green, Mark Lebwohl, Leon H. Kircik, Amy Feng, Scott Snyder, Robert C. Higham, Patrick Burnett, David R. Berk
Publikováno v:
Journal of the American Academy of Dermatology. 87:AB192
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8764100f3a0737cf2a328b65c82a709c
https://doi.org/10.1016/j.jaad.2022.06.799
https://doi.org/10.1016/j.jaad.2022.06.799